在急性心肌梗塞中,完全与仅罪祸首再血管化的比较
1Department of Cardiology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
BMC cardiovascular disorders
|April 25, 2025
概括
针对多血管性疾病的急性心肌梗塞的完整重血管化与仅罪祸首的干预相比,并没有显著减少主要的心血管不良事件. 然而,完全的再血管可能会使高血压患者长期受益.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 心血管医学 心血管医学
背景情况:
- 穿皮冠状动脉干预 (PCI) 是急性心肌梗塞 (AMI) 与多血管疾病 (MVD) 的标准.
- 对于与MVD相关的AMI,PCI在非心脏病相关的动脉中的好处仍在争论中.
- 这项研究评估了在出院前完全与罪祸首仅重血管化的临床结果.
研究的目的:
- 在AMI和MVD患者中,比较完整重血管化 (CR) 与罪祸首仅重血管化 (COR) 的临床结果.
- 评估PCI后1,6和12个月重大心血管和大脑不良事件 (MACCE) 的发生率.
- 确定可能受益于CR的患者子组.
主要方法:
- 173名AMI和MVD患者接受新出现的PCI的回顾性分析 (2013年1月 - 2018年12月).
- 患者被分为CR (n=85) 和COR (n=88) 组.
- 在随访间隔中,MACCE,包括复发性心痛,心脏病发作,静脉栓塞,AF和HF,进行了比较.
主要成果:
- 在1,6或12个月的COR和CR组之间,MACCE没有显著差异 (分别为36.2%和33.3%,42.0%和29.7%,44.9%和36.5%).
- 康复中心小组在6个月内出现重复性心痛的比率显著更高 (20.3%对5.4%).
- 患有高血压的患者在6个月和12个月后表现出CR的改善结果.
结论:
- 在出院前进行完整的血管再循环治疗,与在AMI中患有MVD的患者中仅对罪祸首进行干预相比,没有显著的长期MACCE益处.
- 纯罪恶复血管可能与更高的复发性心痛率有关.
- 高血压是一个潜在的因素,影响完全重血管化的好处.
相关概念视频
01:28Cardiac Catheterization I: Pre-Procedure Overview
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...